InvestorsHub Logo
Followers 120
Posts 20749
Boards Moderated 0
Alias Born 06/13/2011

Re: GD post# 221

Monday, 03/04/2024 6:59:24 PM

Monday, March 04, 2024 6:59:24 PM

Post# of 392
GD. Well it will be a big deal if they see clinical benefit in DME . I'm also in OCUL ..drug eluting inserts , and you're in EYPT ...injections ( but longer duration between shots ? )
If U have time take a look at UNCY. My wife rounds dialysis clinics ( also did CKD research at Yale ). None of her patients are at goal for serum phosphorous.....and none can afford the copay for the new serum phosphorous lower drug ...Xphanozh ? ...unless co ( ARDX ) pays down their copay ( currently $1,000 a mth ) .
The clinical data for OLC ( UNCY ) looks impressive . Co has also just been granted Orphan Drug designation .
However Co has limited cash and looks to need a capital raise to complete their current pivotal trial .
So if you have time , take a look ...let me know if you see any red flags I'm blind to .

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RZLT News